Lupitrix S 1000mg/500mg Injection is a sterile, injectable antibiotic formulation combining Ceftriaxone sodium (1000mg) and Sulbactam sodium (500mg) designed for the treatment of a broad spectrum of bacterial infections. Ceftriaxone, a third-generation cephalosporin, exhibits potent bactericidal activity by inhibiting bacterial cell wall synthesis, while Sulbactam, a beta-lactamase inhibitor, enhances Ceftriaxone’s efficacy by preventing enzymatic degradation of the antibiotic. This combination is effective against various Gram-positive and Gram-negative pathogens, including beta-lactamase producing strains. Indications include respiratory tract infections, urinary tract infections, skin and soft tissue infections, intra-abdominal infections, septicemia, and surgical prophylaxis. Lupitrix S is administered via intramuscular or intravenous injection, with dosage and duration tailored to the severity and type of infection, as well as patient-specific factors such as renal function. The combination offers improved clinical outcomes in resistant infections and reduces the risk of resistance development. Common adverse effects may include injection site reactions, gastrointestinal disturbances, and hypersensitivity reactions. Caution is advised in patients with a history of penicillin or cephalosporin allergy. Lupitrix S should be used under strict medical supervision to ensure optimal therapeutic efficacy and safety.